[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356207-105":59,"doc-detail-356207-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","cd90-promotes-gastric-cancer-progression-by-regulating-slc1a5-mediated-glutamine-metabolism-through-yy1","CD90 Promotes Gastric Cancer Progression by Regulating SLC1A5-Mediated Glutamine Metabolism Through YY1","","CD90 (THY1) is identified as a key cell-surface glycoprotein involved in malignant tumor development, influencing proliferation, metastasis, angiogenesis, stem-like traits, and cellular energy metabolism, while also serving as a biomarker linked to prognosis. The study clarifies how CD90 regulates glutamine metabolism in gastric cancer (GC) cells via SLC1A5. Mechanistically, CD90 enhances YY1 binding to the SLC1A5 promoter, elevating transcription, which in turn modulates SLC1A5-mediated glutamine metabolism and ferroptosis to drive GC progression.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cd90-promotes-gastric-cancer-progression-by-regulating-slc1a5-mediated-glutamine-metabolism-through-yy1/356207/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cd90-promotes-gastric-cancer-progression-by-regulating-slc1a5-mediated-glutamine-metabolism-through-yy1/356207.png","ImageObject",300,407,{"name":92,"@type":93},"MrHarris58","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main finding about CD90 in gastric cancer progression?","Question",{"text":112,"@type":113},"CD90 promotes gastric cancer progression by regulating SLC1A5-mediated glutamine metabolism through YY1-dependent transcriptional activation.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does CD90 mechanistically affect SLC1A5 expression?",{"text":117,"@type":113},"CD90 increases the binding of YY1 to the SLC1A5 promoter, enhances promoter transcriptional activity, and raises SLC1A5 transcriptional levels.",{"name":119,"@type":110,"acceptedAnswer":120},"What downstream processes are influenced by SLC1A5-mediated glutamine metabolism?",{"text":121,"@type":113},"The study links changes in SLC1A5-mediated glutamine metabolism to ferroptosis, ultimately facilitating progression of gastric cancer cells.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356207,1790165906,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687212988360,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Cancer Science  \nORIGINAL ARTICLE  OPEN ACCESS   \nPathology  \nCD90 Promotes Gastric Cancer Progression by Regulating SLC1A5-Mediated Glutamine Metabolism Through YY1  \nZihua Zhou1 | Siyi Liu2  | Chenyu Zhang2 | Jun Deng3 | Lin Liang2,4 | Yanhong Zhou2   \n1Department of Oncology, Loudi Central Hospital, Loudi, China | 2Cancer Research Institute, Basic School of Medicine, Central South University, Changsha, Hunan, China | 3Department of Early Clinical Trail Center, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, Hunan, China | 4Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China  \nCorrespondence: Lin Liang ([lianglin1324@163.com](lianglin1324@163.com)) | Yanhong Zhou ([zhouyanhong@csu.edu.cn](zhouyanhong@csu.edu.cn))  \nReceived: 20 November 2025 | Revised: 19 March 2026 | Accepted: 20 March 2026  \nKeywords: CD90 | gastric cancer | glutamine metabolism | SLC1A5  \nABSTRACT  \nCD90 (THY1) is a cell surface glycoprotein that plays a crucial role in the occurrence and development of various malignant tumors. It affects tumor cell proliferation, metastasis, angiogenesis, stem cell characteristics, and energy metabolism. CD90 is an important biomarker for many malignant tumors and is closely related to tumor prognosis. However, the role and specific mechanisms of CD90 in glutamine metabolism in gastric cancer (GC) cells remain incompletely understood. In this study, we report that CD90 affects glutamine metabolism in GC cells through SLC1A5, ultimately promoting GC progression. Mechanistically, CD90 promotes the binding of YY1 to the SLC1A5 promoter, enhances the transcriptional activity of the SLC1A5 promoter, and increases its transcriptional level. This, in turn, affects SLC1A5-mediated glutamine metabolism and ferroptosis in GC cells, ultimately facilitating GC progression. Our results suggest that CD90 plays an important role in regulating glutamine metabolism in GC cells, providing important experimental evidence for elucidating the pathogenesis of GC.  \n1 | Introduction  \nGastric cancer (GC), including gastroesophageal junction cancer, is the fifth most common cancer worldwide and the fifth leading cause of cancer-related deaths [1] . Globally, the incidence of GC is relatively high in regions such as Asia, Eastern Europe, Central America, and South America, particularly in East Asia [2] . In recent years, immunotherapy, including immune checkpoint inhibitors (ICIs), has opened up new avenues for the treatment of GC [3] . However, the overall survival (OS) rate of GC patients has not significantly improved, especially the 5-year survival rate of advanced GC patients, which is only about 10%[1] . Therefore, a deeper and broader understanding  \nof the pathological mechanisms of GC and the search for new effective prognostic factors and molecular targets are of great significance for improving the survival rate of GC patients.  \nCD90, also known as thymocyte antigen 1 (THY1), is a glycoprotein anchored to glycosylphosphatidylinositol (GPI) with a size of 25–37 kDa. It was first discovered in mouse thymocytes [4–6]. CD90 is expressed in various cell types, including T cells, neurons, endothelial cells, and cancer-associated fibroblasts (CAFs), and plays a key regulatory role in cell communication, cell-extracellular matrix (ECM) interactions, as well as in the immune and nervous systems [7, 8]. The latest research shows that THY1 is overexpressed in cancer stem cells (CSCs) and the tumor  \n\n| Abbreviations: CAFs, cancer-associated fibroblasts; CD90, thymocyte antigen 1; CSCs, cancer stem cells; ECM, extracellular matrix; GC, gastric cancer; GLS, glutaminase; GPI, glycosylphosphatidylinositol; GPNA, L-γ-glutamyl-p-nitroaniline; HNSCC, head and neck squamous cell carcinoma; iCCA, intrahepatic cholangiocarcinoma; ICIs, immune checkpoint inhibitors; MDA, malondialdehyde; OS, overall survival; SLC1A5, solute carrier transporte","cbCaihWm9i0n6sF2","https://ap.wps.com/l/cbCaihWm9i0n6sF2","pdf",6205843,18,"English","# Introduction\n## CD90 and gastric cancer context\n## Glutamine metabolism and therapeutic rationale","[{\"question\":\"What is the main finding about CD90 in gastric cancer progression?\",\"answer\":\"CD90 promotes gastric cancer progression by regulating SLC1A5-mediated glutamine metabolism through YY1-dependent transcriptional activation.\"},{\"question\":\"How does CD90 mechanistically affect SLC1A5 expression?\",\"answer\":\"CD90 increases the binding of YY1 to the SLC1A5 promoter, enhances promoter transcriptional activity, and raises SLC1A5 transcriptional levels.\"},{\"question\":\"What downstream processes are influenced by SLC1A5-mediated glutamine metabolism?\",\"answer\":\"The study links changes in SLC1A5-mediated glutamine metabolism to ferroptosis, ultimately facilitating progression of gastric cancer cells.\"}]","CD90 Promotes Gastric Cancer Progression by Regulating SLC1A5-Mediated Glutamine Metabolism Through YY1 | PDF",1790124061,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ef46f57ba8444789b2d650909236997a.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e82f6c4cd77d452caa84d91ec0e36f2b.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/826623476db06ce4c24fad4a3e36e7c7.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c714a03277c048885bc55b5522c74762.webp",980,1287]